Targeting the Cholinergic System to Develop a Novel Therapy for Huntington's Disease

24Citations
Citations of this article
55Readers
Mendeley users who have this article in their library.

Abstract

In this review, we outline the role of the cholinergic system in Huntington's disease, and briefly describe the dysfunction of cholinergic transmission, cholinergic neurons, cholinergic receptors and cholinergic survival factors observed in post-mortem human brains and animal models of Huntington's disease. We postulate how the dysfunctional cholinergic system can be targeted to develop novel therapies for Huntington's disease, and discuss the beneficial effects of cholinergic therapies in pre-clinical and clinical studies.

Cite

CITATION STYLE

APA

D’Souza, G. X., & Waldvogel, H. J. (2016). Targeting the Cholinergic System to Develop a Novel Therapy for Huntington’s Disease. Journal of Huntington’s Disease. IOS Press. https://doi.org/10.3233/JHD-160200

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free